Jane Street Group, LLC Vyne Therapeutics Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.12 - $4.91 $3,858 - $157,895	-32,158 Reduced 63.52%	18,469 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.24 - $4.27 $12,150 - $216,177	50,627 New	50,627 $11,000
Q2 2022 Aug 16, 2022	SELL	$0.37 - $0.71 $4,478 - $8,593	-12,104 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$0.5 - $1.15 $6,609 - $15,200	-13,218 Reduced 52.2%	12,104 $8,000
Q4 2021 Feb 15, 2022	BUY	$0.91 - $1.5 $23,043 - $37,983	25,322 New	25,322 $26,000
Q2 2021 Aug 16, 2021	SELL	$3.24 - $6.92 $54,525 - $116,456	-16,829 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$6.34 - $12.68 $106,695 - $213,391	16,829 New	16,829 $115,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $170M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.